Meningitis VaccineThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you your search results in order of date.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

1985 records returned

FDA Advisory Committee Finds Data Support The Safety And Effectiveness Of Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal DiseasEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pfizer Inc (NYSE:PFE) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for the prevention of invasive pneumococcal disease in infants and young children. (Source: Immune System / Vaccines News From Medical News Today)
Source: Immune System / Vaccines News From Medical News Today - November 20, 2009 Category: Allergy & Immunology Tags: Immune System / vaccines Source Type: news

FDA Panel Recommends Prevnar 13 Vaccine for ApprovalEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
An advisory committee voted 10 to 1 (with 1 abstention) to approve Pfizer's request for licensure of Prevnar 13 to immunize infants and children against invasive pneumococcal disease. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 19, 2009 Category: Consumer Health News Tags: Infectious Diseases Source Type: news

Pneumococcal conjugate vaccines effective at preventing child deaths, study suggestsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A new study concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and X-ray defined pneumonia, were also effective against child deaths. According to the review, 80 percent of children were less likely to develop vaccine-type IPD, 58 percent all-serotype IPD, and 27 percent x-ray defined pneumonia than children who did not receive the vaccine. Eleven percent of child deaths were also prevented. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 18, 2009 Category: Science Source Type: news

Elimination of False Positive Results in a Luminex assay for Pneumococcal Antibodies.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We describe here methods that eliminated the false positive reactivity of both groups. PMID: 19923569 [PubMed - as supplied by publisher] (Source: Clinical and Vaccine Immunology)
Source: Clinical and Vaccine Immunology - November 18, 2009 Category: Allergy & Immunology Authors: Pickering JW, Larson MT, Martins TB, Copple SS, Hill HR Tags: Clin vaccine Immunol Source Type: journals

Vaccines: Hyperhaemolysis (first reports with meningococcal vaccine groups A C Y W-135 polysaccharide and Hib vaccine conjugate) in an EBV-infected patient: case reportEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Reactions)
Source: Reactions - November 16, 2009 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals

Pneumococcal vaccines: search for an optimal agentEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 15, 2009 Category: Health Management Tags: Short communication Source Type: journals

The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cellsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
It was recently shown that bacterial thymus-independent (TI) antigens confer long-lasting immunity and generate memory B lymphocytes. However, reactivation of TI memory B cells is repressed in immunocompetent mice, thus raising the issue of the mechanism whereby TI vaccines confer immune protection. Here, we propose an explanation to this apparent paradox by showing that a Streptococcus pneumoniae capsular polysaccharide (PS) generates long-lived bone marrow (BM) plasma cells which frequency can be increased by CpG oligodeoxynucleotides (ODNs). The adjuvant effect of CpG ODNs on the PS3 Ab response is directly targeted to ...
Source: Blood - November 12, 2009 Category: Hematology Authors: Taillardet, M., Haffar, G., Mondiere, P., Asensio, M.-J., Gheit, H., Burdin, N., Defrance, T., Genestier, L. Tags: Immunobiology Source Type: journals

Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We evaluated a multiplexed bead-based assay (xMAP(R) Pneumococcal Immunity assay from Luminex) for the simultaneous determination of antibodies against 14 capsular polysaccharides. Post-vaccination (Pneumovax(R)) antibody concentrations were measured in 35 healthy children, 40 healthy adults, 99 consecutive patients with increased susceptibility to respiratory infection, and 24 patients with a deficient anti-polysaccharide antibody response. The serotype-specific lower 5th percentile (cutoff) value for the post-immunization antibody concentration was determined in healthy individuals. Eleven of 99 patients (11%) failed...
Source: Clinical Immunology - November 12, 2009 Category: Allergy & Immunology Authors: Borgers H, Moens L, Picard C, Jeurissen A, Raes M, Sauer K, Proesmans M, De Boeck K, Casanova JL, Meyts I, Bossuyt X Tags: Clin Immunol Source Type: journals

Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine at 12 to 15 months of age in healthy UK infants primed with two doses of one of three monovalent meningococcal serogroup C vaccines.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The kinetics of antibody persistence following the administration of a combination meningococcal serogroup C and Haemophilus influenzae type b (Hib) conjugate vaccine (Menitorix) in the second year of life in children primed with two doses of one of three monovalent meningococcal serogroup C (MCC) vaccines was investigated. Study subjects were either administered Menitorix at 12 to 15 months of age followed by the 7-valent pneumococcal conjugate (PCV7) and measles, mumps and rubella (MMR) vaccine 4 to 6 weeks later or all three vaccines concomitantly at 12 to 15 months of age. Blood samples were collected before and 1,...
Source: Clinical and Vaccine Immunology - November 11, 2009 Category: Allergy & Immunology Authors: Borrow R, Andrews N, Findlow H, Waight P, Southern J, Crowley-Luke A, Stapley L, England A, Findlow J, Miller E Tags: Clin vaccine Immunol Source Type: journals

Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Journal of Antimicrobial Chemotherapy)
Source: Journal of Antimicrobial Chemotherapy - November 10, 2009 Category: Microbiology Authors: Fenoll, A., Gimenez, M.-J., Vicioso, M.-D., Granizo, J.-J., Robledo, O., Aguilar, L. Tags: Research letters Source Type: journals

Letter to Providers Promoting PPSV for AdultsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pneumococcal infections have been identified as an important complication in severe and fatal cases of 2009 H1N1 influenza virus infection. CDC has written a letter to providers urging them to make sure all their adult patients with indications have received the pneumococcal polysaccharide vaccine. (Source: CDC Swine Flu Updates)
Source: CDC Swine Flu Updates - November 10, 2009 Category: Infectious Diseases Source Type: organizations

Uptake of Adult Vaccination Varies Widely in Urban AreasEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
There are wide variations in the uptake of pneumococcal polysaccharide vaccine and influenza vaccine in adults in urban areas, and physicians' practice characteristics influence the likelihood of their patients getting vaccinated, according to a study in the November/December Annals of Family Medicine. (Source: Modern Medicine)
Source: Modern Medicine - November 10, 2009 Category: Journals (General) Source Type: info

WHO Grants Prequalification for Global Use to GSK's 10-Valent Synflorix™ VaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The World Health Organization (WHO) has awarded prequalification for global use of Synflorix™, GlaxoSmithKline Biologicals' pneumococcal conjugate vaccine. This is the first prequalification for a vaccine against pneumococcal disease, which is a life-threatening disease affecting many children under five in developing countries. (Source: World Pharma News)
Source: World Pharma News - November 9, 2009 Category: Pharmaceuticals Source Type: news

CDC Health Alert Network (HAN) Info Service Message: 2009 H1N1 Pandemic Update: Pneumococcal Vaccination Recommended to Help Prevent Secondary InfectionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The 2009 pandemic H1N1 influenza virus continues to be the dominant influenza virus in circulation in the U.S. The benefit of antiviral treatment is greatest when it is initiated as early as possible in the clinical course. (Source: CDC Swine Flu Updates)
Source: CDC Swine Flu Updates - November 6, 2009 Category: Infectious Diseases Source Type: organizations

Meningococcal Vaccines: A Neglected Topic in Travel Medicine?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Awareness of the risk for meningococcal disease among travelers is generally poor, even though case fatality rates are high and the disease can be fatal within 24 hours. Expert Review of Vaccines (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 6, 2009 Category: Drugs & Pharmacology Tags: Infectious Diseases Source Type: info

World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ VaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Endorsement is first for vaccine for pneumococcal disease - a life-threatening disease affecting many children; follows first-ever World Pneumonia Day (Source: GSK news)
Source: GSK news - November 6, 2009 Category: Pharmaceuticals Source Type: organizations

Issues in pneumococcal disease and pneumococcal conjugate vaccines: highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9-13, 2009.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The 27th annual meeting of the European Society for Paediatric Infectious Diseases (ESPID), held in Brussels, Belgium, addressed serious bacterial infections. The scientific program included international experts who provided insights into and discussions on the epidemiology, diagnosis, prevention, treatment, and clinical presentation of important pediatric infectious diseases. This conference report offers highlights of presentations addressing pneumococcal disease and pneumococcal conjugate vaccines. PMID: 19883868 [PubMed - in process] (Source: Vaccine)
Source: Vaccine - November 5, 2009 Category: Allergy & Immunology Authors: Adam D Tags: vaccine Source Type: journals

New Safety Data on Menactra for InfantsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Sanofi Pasteur Presents Safety Data on Menactra® Vaccine Given to Infants at Infectious Disease Society Meeting The two-dose meningococcal quadrivalent conjugate vaccine was generally well-tolerated Philadelphia, PA – November 2, 2009... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 5, 2009 Category: Pharmaceuticals Source Type: clinical trials

Evaluation of pneumococcal polysaccharide immunoassays using 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The history of pneumococcal polysaccharide ELISA is characterized by a continuous search for increased specificity. A third generation ELISA using 22F polysaccharide inhibition has increased assay specificity particularly at low antibody concentrations. In the present work, various 22F/non-22F ELISA comparisons were made, involving three different laboratories, including a WHO reference laboratory, and using sera from subjects from different geographic areas immunized with different pneumococcal conjugate vaccines, including the licensed 7-valent Prevenar(TM) and 10-valent Synflorix(TM). All comparisons led to the same...
Source: Clinical and Vaccine Immunology - November 4, 2009 Category: Allergy & Immunology Authors: Poolman JT, Frasch CE, Käyhty H, Lestrate P, Madhi SA, Henckaerts I Tags: Clin vaccine Immunol Source Type: journals

Haemophilus influenzae serotype a meningitis.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This work describes a case of Haemophilus influenzae serotype a meningitis in Brazil, after almost a decade since the introduction of Haemophilus influenzae serotype b conjugate vaccine. Uncertainty about the replacement of H. influenzae serotypes as a cause of invasive diseases justifies continuous surveillance, coupled with investigations of carriage rates and requirements of chemoprophylaxis in contact persons. PMID: 19880770 [PubMed - in process] (Source: Annals of Clinical and Laboratory Science)
Source: Annals of Clinical and Laboratory Science - November 3, 2009 Category: Laboratory Medicine Authors: de Pádua RA, de Lima Scodro RB, Ghiraldi LD, Siqueira VL, Yamashita YK, Helbel C, Cardoso RF Tags: Ann Clin Lab Sci Source Type: journals

ProQuadEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Approval Letter and Approved Final Draft Labeling for Merck's Efficacy Supplement for Measles, Mumps, Rubella, and Varicella Vaccine, Live, (ProQuad®), to include concomitant administration with hepatitis A vaccine (VAQTA®) and/or pneumococcal conjugate vaccine (Prevnar®), use of ProQuad® in children 15 months to 12 years of age if a second dose of measles, mumps, rubella, and varicella is needed, additional safety data after a first or second dose of ProQuad®, and to comply with the Physician’s Labeling Rule format, have been issued. (Source: What's New at CBER)
Source: What's New at CBER - November 3, 2009 Category: Biomedical Science Source Type: organizations

Sanofi Pasteur Presents Safety Data on Menactra Vaccine Given to Infants at Infectious Disease Society MeetingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The two-dose meningococcal quadrivalent conjugate vaccine was generally well-tolerated PHILADELPHIA, Nov. 2 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), presented Safety of a... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 3, 2009 Category: Pharmaceuticals Source Type: clinical trials

Sanofi Pasteur Presents Safety Data On Menactra(R) Vaccine Given To Infants At Infectious Disease Society MeetingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), presented Safety of a Quadrivalent (A,C,Y,W-135) Meningococcal Vaccine When Given to Infants with Other Pediatric Vaccines at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) this past weekend. (Source: Immune System / Vaccines News From Medical News Today)
Source: Immune System / Vaccines News From Medical News Today - November 3, 2009 Category: Allergy & Immunology Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: Demand, supply and seasonality.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Background: In February 2005, the US Advisory Committee on Immunization Practices recommended the new meningococcal conjugate vaccine (MCV4) for routine use among 11- to 12-year-olds (at the preadolescent health-care visit), 14- to 15-year-olds (before high-school entry), and groups at increased risk. Vaccine distribution started in March; however, in July, the manufacturer reported inability to meet demand and widespread MCV4 shortages were reported. Our objectives were to determine early uptake patterns among target (11-12 and 14-15 year olds) and non-target (13- plus 16-year-olds) age groups. A post hoc analysis was con...
Source: BMC Infectious Diseases - November 3, 2009 Category: Infectious Diseases Authors: Suchita LorickDaniel FishbeinEric WeintraubPascale WortleyGrace LeeFangjun ZhouRobert Davis Source Type: journals

Pneumonia vaccine could save money in flu pandemicEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CHICAGO (Reuters) - A more protective form of Pfizer's vaccine for pneumococcal disease would be highly effective at preventing deaths from pandemic influenza, independent researchers and the company reported over the weekend. (Source: Reuters: Health)
Source: Reuters: Health - November 2, 2009 Category: Consumer Health News Tags: healthNews Source Type: news

Viral meningitis and encephalitisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Abstract: Meningitis and encephalitis due to virus infections occur at all stages of life from the neonate to the elderly and may represent disease due to the primary site of replication, e.g. rabies, or be part of a wider infection syndrome, e.g. HIV. A large proportion of cases go unconfirmed by laboratory diagnosis despite use of sensitive techniques (such as the polymerase chain reaction). They may be both sporadic and epidemic in nature, but with changing environmental and societal conditions, agents may emerge anew, e.g. Nipah and Hendra viruses, or reappear after a period of good control through vaccination, e.g. mu...
Source: Medicine - November 1, 2009 Category: Internal Medicine Authors: Philip Rice Tags: Nervous system infections Source Type: journals

Clinical inquiries. Which asthma patients should get the pneumococcal vaccine?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PMID: 19891942 [PubMed - in process] (Source: The Journal of Family Practice)
Source: The Journal of Family Practice - November 1, 2009 Category: Practice Management Authors: Harris JB, Edgerton L, Stafford K Tags: J Fam Pract Source Type: journals

Understanding adult vaccination in urban, lower-socioeconomic settings: influence of physician and prevention systems.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSIONS: Vaccination rates vary widely in urban settings and are associated with practice characteristics such as time spent with patients and, for influenza vaccine, use of standing orders. PMID: 19901313 [PubMed - in process] (Source: Annals of Family Medicine)
Source: Annals of Family Medicine - November 1, 2009 Category: Primary Care Authors: Zimmerman RK, Nowalk MP, Tabbarah M, Hart JA, Fox DE, Raymund M, Tags: Ann Fam Med Source Type: journals

Profit Driven Swine Flu Propaganda - Pump Up the Volume - Part FiveEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article is part five in a six-part series. Be sure to read part four at http://www.naturalnews.com/027336_swine_flu_health_propaganda.htmlIn the video commentary titled, Mild Swine Flu and Over-Hyped Vaccine, on the website for the National Vaccine Information Center, the group's co-founder and president, Barbara Loe Fisher, reports: "We are witnessing a roll-out of the largest, most expensive mass vaccination campaign in the history of our nation. A rollout that is bigger than even the polio vaccine campaigns of the 1950's.""If you or your child are injured from getting a flu swine flu shot, you are on your own," Fis...
Source: NaturalNews.com - October 30, 2009 Category: Consumer Health Advice Source Type: news

[Seminar] Pathogenesis, treatment, and prevention of pneumococcal pneumoniaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pneumococcus remains the most common cause of community-acquired pneumonia worldwide. Streptococcus pneumoniae is well adapted to people, and is a frequent inhabitant of the upper airways in healthy hosts. This seemingly innocuous state of colonisation is a dynamic and competitive process in which the pathogen attempts to engage the host, proliferate, and invade the lower airways. The host in turn continuously deploys an array of innate and acquired cellular and humoral defences to prevent pneumococci from breaching tissue barriers. Discoveries into essential molecular mechanisms used by pneumococci to evade host-sensing s...
Source: LANCET - October 30, 2009 Category: Journals (General) Authors: Tom van der Poll, Steven M Opal Tags: Seminar Source Type: journals

Review: Pathogenesis, treatment, and prevention of pneumococcal pneumoniaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: Lancet Area: News Pneumococcus remains the most common cause of community-acquired pneumonia worldwide and this review on pneumococcal pneumonia in the Lancet covers the following topics: . Epidemiology . Genetics and virulence of S pneumoniae . Pneumococcal virulence factors . Mechanisms of host recognition . Immunology . Clinical features . Diagnosis . Treatment . Vaccine strategies (Source: NeLM - Respiratory Medicine)
Source: NeLM - Respiratory Medicine - October 30, 2009 Category: Respiratory Medicine Source Type: organizations

Children "better off" without seasonal flu vaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Seasonal flu infection could give some protection against pandemic strainsRelated items from OnMedicaRise in group B meningitis infectionsScottish Bill passed to protect public from contaminationMeasles programme must be stepped-upMMR vaccine uptake faltersNo deaths from meningitis C last year (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 30, 2009 Category: UK Health Source Type: news

Children 'better off' without seasonal flu vaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Seasonal flu infection could give some protection against pandemic strainsRelated items from OnMedicaRise in group B meningitis infectionsScottish Bill passed to protect public from contaminationMeasles programme must be stepped-upMMR vaccine uptake faltersNo deaths from meningitis C last year (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 30, 2009 Category: UK Health Source Type: news

Preparation and immunogenicity of capsular polysaccharide-surface adhesin A (PsaA) conjugate of Streptococcuspneumoniae.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The efforts were focused on exploring alternative pneumococcal vaccine strategies, aimed at addressing the shortcomings of existing formulations, without compromising efficacy. We generated a stable Escherichiacoli construct expressing functional recombinant PsaA and prepared CPS-rPsaA conjugate. The distribution of anti-CPS antibody response was almost completely of IgG2a subclass followed by IgG3 and low level of IgG1 subclass, which was opposite to the distribution of anti-PsaA IgG subclass antibodies. Though rPsaA was not detectable on the surface of the pneumococcal strain, the CPS-rPsaA conjugate possessed more a...
Source: Immunobiology - October 30, 2009 Category: Allergy & Immunology Authors: Lin H, Lin Z, Meng C, Huang J, Guo Y Tags: Immunobiology Source Type: journals

Outbreak Of Poliomyelitis In Finland In 1984-85 - Re-Analysis Of Viral Sequences Using The Current Standard Approach.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In 1984, a wild type 3 poliovirus (PV3/FIN84) spread all over Finland causing nine cases of paralytic poliomyelitis and one case of aseptic meningitis. The outbreak was ended in 1985 with an intensive vaccination campaign. By limited sequence comparison with previously isolated PV3 strains, closest relatives of PV3/FIN84 were found among strains circulating in the Mediterranean region. Now we wanted to reanalyse the relationships using approaches currently exploited in poliovirus surveillance. Cell lysates of twenty strains isolated during the outbreak and stored frozen were subjected to RT-PCR amplification in three g...
Source: Virus Research - October 30, 2009 Category: Virology Authors: Simonen ML, Roivainen M, Iber J, Burns C, Hovi T Tags: Virus Res Source Type: journals

Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alertEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
To examine whether an electronic health record (EHR) best practice alert (BPA), a clinical reminder to help guideline adherence, improved vaccination rates in rheumatology patients receiving immunosuppressants. Guidelines recommend yearly influenza and pneumococcal vaccination with revaccination for patients age >65 years who are taking immunosuppressive medications.A vaccination BPA was developed based on immunosuppressant treatment, age, and prior vaccinations. At site 1, a hospital-based academic practice, physicians ordered vaccinations. At site 2, a community-based practice, physicians signed orders placed by nurses. ...
Source: Arthritis Care and Research - October 29, 2009 Category: Rheumatology Authors: Lindsay J. Ledwich, Thomas M. Harrington, William T. Ayoub, Jennifer A. Sartorius, Eric D. Newman Tags: Preventive Care Source Type: journals

Medicine Looks Ahead at TED MEDEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
“If you open your minds and let your imaginings run wild, you can see.” J. Craig Venter, the genomic scientist and founder of the J. Craig Venter Institute, was speaking yesterday about the potential for techniques involved in the field of synthetic life to improve medicine, but his words could have been applied to the all the talks during the opening session of TED MED (“TED” is for technology, entertainment, design). The conference is running from October 27 through 30 at the Hotel Del Coronado in San Diego. Speakers also described advances in using stem cells for regenerative medicine and tissue ...
Source: Scientific American Topic - Medical Technology - October 28, 2009 Category: Consumer Health News Tags: Health & Medicine,Medical Technology Source Type: info

Medicine Looks Ahead at TED MEDEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
“If you open your minds and let your imaginings run wild, you can see.” J. Craig Venter, the genomic scientist and founder of the J. Craig Venter Institute, was speaking yesterday about the potential for techniques involved in the field of synthetic life to improve medicine, but his words could have been applied to the all the talks during the opening session of TED MED (“TED” is for technology, entertainment, design). The conference is running from October 27 through 30 at the Hotel Del Coronado in San Diego. Speakers also described advances in using stem cells for regenerative medicine and tissue ...
Source: Scientific American - Official RSS Feed - October 28, 2009 Category: Science Tags: Health & Medicine,Medical Technology Source Type: journals

Medicine looks ahead at TED MEDEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
“If you open your minds and let your imaginings run wild, you can see.” J. Craig Venter, the genomic scientist and founder of the J. Craig Venter Institute, was speaking yesterday about the potential for techniques involved in the field of synthetic life to improve medicine, but his words could have been applied to the all the talks during the opening session of TED MED (“TED” is for technology, entertainment, design). The conference is running from October 27 through 30 at the Hotel Del Coronado in San Diego. Speakers also described advances in using stem cells for regenerative medicine and tissue ...
Source: Scientific American Topic - Stem Cell Research - October 28, 2009 Category: Stem Cells Tags: Health & Medicine,Medical Technology Source Type: info

Teenagers Difficult To 'Capture' For Vaccinations; Rates On Rise Overall, But Still LowEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
More teenagers are being vaccinated against human papillomavirus (HPV), meningococcal meningitis and pertussis (whooping cough), though the rates are still too low, according to recently released government data and a panel of experts convened by the National Foundation for Infectious Diseases (NFID). (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 27, 2009 Category: Consumer Health News Tags: Cervical Cancer / HPV vaccine Source Type: news

The Impact of the Pneumococcal Conjugate Vaccine on Antimicrobial Resistance in the United States Since 1996: Evidence for a Significant Rebound by 2007 in Many Classes of AntibioticsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Microbial Drug Resistance Dec 2009, Vol. 15, No. 4: 261-268. (Source: Microbial Drug Resistance)
Source: Microbial Drug Resistance - October 26, 2009 Category: Microbiology Tags: article Source Type: journals

Streptococcus pneumoniae Nasopharyngeal Carriage in Children Attending Day-Care Centers in the Central Region of Portugal, In the Era of 7-Valent Pneumococcal Conjugate VaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Microbial Drug Resistance Dec 2009, Vol. 15, No. 4: 269-277. (Source: Microbial Drug Resistance)
Source: Microbial Drug Resistance - October 26, 2009 Category: Microbiology Tags: article Source Type: journals

Prevalence of serotypes and antimicrobial resistance of invasive strains of pneumococcus in children: analysis of 9 years.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSIONS: Penicillin resistance was detected in 9.9% of the strains, being predominant from 2004 to 2008. Twenty different pneumococcal serotypes were identified, and 71.9% of the serotypes were represented in the 7-valent conjugate vaccine (PN CRM7) currently available. PMID: 19859623 [PubMed - as supplied by publisher] (Source: Jornal de Pediatria)
Source: Jornal de Pediatria - October 26, 2009 Category: Pediatrics Authors: Mantese OC, de Paula A, Almeida VV, de Aguiar PA, Wolkers PC, Alvares JR, Almeida SC, Guerra ML, Brandileone MC Tags: J Pediatr (Rio J) Source Type: journals

For Providers: Prevention of Pneumococcal Infections Secondary to Seasonal and 2009 H1N1 Influenza Viruses InfectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This update provides information about pneumococcal disease as a complication of influenza, including ACIP recommendations for pneumococcal polysaccharide vaccine. (Source: CDC Swine Flu Updates)
Source: CDC Swine Flu Updates - October 23, 2009 Category: Infectious Diseases Source Type: organizations

Questions and Answers: Prevention of Pneumococcal Infections Secondary to Seasonal and 2009 H1N1 InfluenzaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This update provides information about pneumococcal disease, including who is at high risk and needs to be vaccinated. (Source: CDC Swine Flu Updates)
Source: CDC Swine Flu Updates - October 23, 2009 Category: Infectious Diseases Source Type: organizations

Panel reviews recommendations for 13-valent pneumococcal conjugate vaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Read the full story on MD Consult: Panel reviews recommendations for 13-valent pneumococcal conjugate vaccine (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - October 23, 2009 Category: Journals (General) Source Type: info

The immunologic paradox in the diagnosis of tuberculous meningitis.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We report a patient with microbiologically documented tuberculous meningitis showing that the therapeutic paradox, a therapy-induced switch to a neutrophil-predominant situation in the differential cell count of cerebrospinal fluid, had a correlation with a immunologic paradox, a increased Mycobacterium tuberculosis-specific IFN-gamma-producing T cell response. PMID: 19846679 [PubMed - as supplied by publisher] (Source: Clinical and Vaccine Immunology)
Source: Clinical and Vaccine Immunology - October 20, 2009 Category: Allergy & Immunology Authors: Kim SH, Kim YS Tags: Clin vaccine Immunol Source Type: journals

Also notedEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This study examines whether the pain response to administration of the diphtheria, polio, and tetanus toxoids and acellular pertussis and Haemophilus influenzae type b vaccine and the pneumococcal conjugate vaccine is affected by the order in which they are given. With the validated Modified Behavioral Pain Scale, videotaped recordings of the procedure (to assess crying), and parental ratings of pain on a visual analog scale, they found that children had less pain (on all 3 measures) when the diphtheria, polio, and tetanus toxoids and acellular pertussis and diphtheria, polio, and tetanus toxoids and acellular pertussis an...
Source: The Journal of Pediatrics - October 20, 2009 Category: Pediatrics Tags: Current Best Evidence Source Type: journals

Pneumococcal Conjugate Vaccines Effective At Preventing Child DeathsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A study published in The Cochrane Review this month concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and x-ray defined pneumonia, was also effective against child deaths. The findings were based on a systematic review of the results of 6 randomized and controlled trials conducted in the US, Africa, Philippines, and Finland. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 20, 2009 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news